JP2632849B2 - γ―インターフェロンの製造方法 - Google Patents

γ―インターフェロンの製造方法

Info

Publication number
JP2632849B2
JP2632849B2 JP62125777A JP12577787A JP2632849B2 JP 2632849 B2 JP2632849 B2 JP 2632849B2 JP 62125777 A JP62125777 A JP 62125777A JP 12577787 A JP12577787 A JP 12577787A JP 2632849 B2 JP2632849 B2 JP 2632849B2
Authority
JP
Japan
Prior art keywords
interferon
cells
human
producing
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP62125777A
Other languages
English (en)
Japanese (ja)
Other versions
JPS63152993A (ja
Inventor
雅司 栗本
正和 三橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Priority to CA000542760A priority Critical patent/CA1340698C/en
Priority to FI873237A priority patent/FI873237L/fi
Priority to NO873120A priority patent/NO173144C/no
Priority to DE3752184T priority patent/DE3752184T2/de
Priority to DK388787A priority patent/DK388787A/da
Priority to EP87306585A priority patent/EP0254593B1/en
Priority to GB8717610A priority patent/GB2194240B/en
Priority to ES87306585T priority patent/ES2115582T3/es
Priority to AU76105/87A priority patent/AU605492B2/en
Priority to KR1019870008098A priority patent/KR970002165B1/ko
Priority to FR878711709A priority patent/FR2615737B1/fr
Publication of JPS63152993A publication Critical patent/JPS63152993A/ja
Priority to US08/062,323 priority patent/US5362490A/en
Priority to US08/336,224 priority patent/US5518899A/en
Priority to US08/476,040 priority patent/US5554515A/en
Priority to US08/625,369 priority patent/US5672692A/en
Application granted granted Critical
Publication of JP2632849B2 publication Critical patent/JP2632849B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249—Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP62125777A 1986-07-25 1987-05-25 γ―インターフェロンの製造方法 Expired - Lifetime JP2632849B2 (ja)

Priority Applications (15)

Application Number Priority Date Filing Date Title
CA000542760A CA1340698C (en) 1986-07-25 1987-07-22 Preparation and uses of interferon-gamma
FI873237A FI873237L (fi) 1986-07-25 1987-07-23 Framstaellning och anvaendning av interferon-gamma.
AU76105/87A AU605492B2 (en) 1986-07-25 1987-07-24 Preparation and uses of interferon-gamma
DE3752184T DE3752184T2 (de) 1986-07-25 1987-07-24 Herstellung und Verwendungen von gamma-Interferon
DK388787A DK388787A (da) 1986-07-25 1987-07-24 Fremgangsmaade til fremstilling af interferon
EP87306585A EP0254593B1 (en) 1986-07-25 1987-07-24 Preparation and uses of interferon-gamma
GB8717610A GB2194240B (en) 1986-07-25 1987-07-24 Preparation and uses of interferon-gamma
ES87306585T ES2115582T3 (es) 1986-07-25 1987-07-24 Preparacion y aplicaciones de interferon-gamma.
NO873120A NO173144C (no) 1986-07-25 1987-07-24 Fremgangsmaate til fremstilling av interferongamma
KR1019870008098A KR970002165B1 (ko) 1986-07-25 1987-07-25 γ-인터페론의 제조방법과 그 용도
FR878711709A FR2615737B1 (fr) 1986-07-25 1987-08-19 Preparation et utilisation d'interferon-gamma
US08/062,323 US5362490A (en) 1986-07-25 1993-05-17 Human myelomonocyte interferon-gamma, and process for preparation and use thereof
US08/336,224 US5518899A (en) 1986-07-25 1994-11-07 Preparation of human myelomonocyte interferon-gamma
US08/476,040 US5554515A (en) 1986-07-25 1995-06-07 Preparation of a monoclonal antibody specific to human myelomonocyte interferon-gamma
US08/625,369 US5672692A (en) 1986-07-25 1996-04-01 Purification of human myelomonocyte interferon gamma with an immobilized antibody

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61-176266 1986-07-25
JP17626686 1986-07-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP8299887A Division JP2850293B2 (ja) 1996-10-25 1996-10-25 γ−インターフェロン感受性疾患剤

Publications (2)

Publication Number Publication Date
JPS63152993A JPS63152993A (ja) 1988-06-25
JP2632849B2 true JP2632849B2 (ja) 1997-07-23

Family

ID=16010565

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62125777A Expired - Lifetime JP2632849B2 (ja) 1986-07-25 1987-05-25 γ―インターフェロンの製造方法

Country Status (3)

Country Link
JP (1) JP2632849B2 (2)
KR (1) KR970002165B1 (2)
IN (1) IN165716B (2)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
JP2007282630A (ja) * 2006-03-22 2007-11-01 Glycomedics Inc オリゴ糖鎖合成方法

Also Published As

Publication number Publication date
KR970002165B1 (ko) 1997-02-24
JPS63152993A (ja) 1988-06-25
IN165716B (2) 1989-12-23
KR880001806A (ko) 1988-04-27

Similar Documents

Publication Publication Date Title
NL192086C (nl) Werkwijze ter bereiding van interferonen en werkwijze ter bereiding van een geneesmiddel dat interferonen bevat.
US5554515A (en) Preparation of a monoclonal antibody specific to human myelomonocyte interferon-gamma
JPS631296B2 (2)
US4758549A (en) Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
JPS6227048B2 (2)
EP0254593B1 (en) Preparation and uses of interferon-gamma
JP2632849B2 (ja) γ―インターフェロンの製造方法
US5002878A (en) Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses
JP2926409B2 (ja) 癌転移抑制因子の製造方法
JP2850293B2 (ja) γ−インターフェロン感受性疾患剤
CA1295241C (en) Lymphokine and its production and uses
JP2566761B2 (ja) 骨髄単球系細胞
JPH0214039B2 (2)
JP2532025B2 (ja) 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
JPH0446928B2 (2)
JPH0527640B2 (2)
JPH0523755B2 (2)
JPH0526468B2 (2)
JPS6323176B2 (2)
JPH0811759B2 (ja) 新リンホカイン▲ｉｉ▼とその製法および用途
JPH0574575B2 (2)
JPS61115099A (ja) モノクロ−ナル抗体とその製法

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20080425

Year of fee payment: 11